Literature DB >> 15141310

Sequential proteome alterations during genesis and progression of colon cancer.

U J Roblick1, D Hirschberg, J K Habermann, C Palmberg, S Becker, S Krüger, M Gustafsson, H-P Bruch, B Franzén, T Ried, T Bergmann, G Auer, H Jörnvall.   

Abstract

Changes in the proteome of colon mucosal cells accompany the transition from normal mucosa via adenoma and invasive cancer to metastatic disease. Samples from 15 patients with sporadic sigmoid cancers were analyzed. Proteins were separated by two-dimensional gel electrophoresis. Relative differences in expression levels between normal tissue, adenoma, carcinoma and metastasis were evaluated in both intra- and inter-patient comparisons. Up- and down-regulated proteins (> twofold) during development to cancer or metastasis were excised and submitted to peptide mass fingerprinting and MS/MS sequence analysis, facilitated by the use of a compact disc workstation. In total, 112 protein spots were found to be differentially regulated, of which 72 were determined as to protein identity, 46 being up-regulated toward the progression of cancer, and 26 down-regulated. Several of the identifications correlate with proteins of the cell cycle, cytoskeleton or metabolic pathways. The pattern changes now identified have the potential for design of marker panels for assistance in diagnostics and therapeutic strategies in colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15141310     DOI: 10.1007/s00018-004-4049-4

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  52 in total

1.  Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants.

Authors: 
Journal:  Lancet       Date:  1997-08-16       Impact factor: 79.321

Review 2.  Nitrate therapy: new aspects concerning molecular action and tolerance.

Authors:  Thomas Münzel; Andreas Daiber; Tommaso Gori
Journal:  Circulation       Date:  2011-05-17       Impact factor: 29.690

3.  Primary prevention of cardiovascular disease with a Mediterranean diet.

Authors:  Ramón Estruch; Emilio Ros; Jordi Salas-Salvadó; Maria-Isabel Covas; Dolores Corella; Fernando Arós; Enrique Gómez-Gracia; Valentina Ruiz-Gutiérrez; Miquel Fiol; José Lapetra; Rosa Maria Lamuela-Raventos; Lluís Serra-Majem; Xavier Pintó; Josep Basora; Miguel Angel Muñoz; José V Sorlí; José Alfredo Martínez; Miguel Angel Martínez-González
Journal:  N Engl J Med       Date:  2013-02-25       Impact factor: 91.245

4.  Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.

Authors:  Friedrich W Mohr; Marie-Claude Morice; A Pieter Kappetein; Ted E Feldman; Elisabeth Ståhle; Antonio Colombo; Michael J Mack; David R Holmes; Marie-angèle Morel; Nic Van Dyck; Vicki M Houle; Keith D Dawkins; Patrick W Serruys
Journal:  Lancet       Date:  2013-02-23       Impact factor: 79.321

5.  Smoking ban in public areas is associated with a reduced incidence of hospital admissions due to ST-elevation myocardial infarctions in non-smokers. Results from the Bremen STEMI Registry.

Authors:  J Schmucker; H Wienbergen; S Seide; E Fiehn; A Fach; B Würmann-Busch; H Gohlke; K Günther; W Ahrens; R Hambrecht
Journal:  Eur J Prev Cardiol       Date:  2013-04-30       Impact factor: 7.804

6.  Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.

Authors:  Jean-Claude Tardif; Ian Ford; Michal Tendera; Martial G Bourassa; Kim Fox
Journal:  Eur Heart J       Date:  2005-10-07       Impact factor: 29.983

7.  β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.

Authors:  Sripal Bangalore; Gabriel Steg; Prakash Deedwania; Kevin Crowley; Kim A Eagle; Shinya Goto; E Magnus Ohman; Christopher P Cannon; Sidney C Smith; Uwe Zeymer; Elaine B Hoffman; Franz H Messerli; Deepak L Bhatt
Journal:  JAMA       Date:  2012-10-03       Impact factor: 56.272

Review 8.  Smoking cessation for the secondary prevention of coronary heart disease.

Authors:  J Critchley; S Capewell
Journal:  Cochrane Database Syst Rev       Date:  2004

9.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

10.  Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.

Authors:  Kim Fox; Ian Ford; Ph Gabriel Steg; Michal Tendera; Michele Robertson; Roberto Ferrari
Journal:  Eur Heart J       Date:  2009-08-31       Impact factor: 29.983

View more
  17 in total

1.  Identification of endothelial proteins by MALDI-MS using a compact disc microfluidic system.

Authors:  Daniel Hirschberg; Sam Tryggvason; Magnus Gustafsson; Tomas Bergman; Jesper Swedenborg; Ulf Hedin; Hans Jörnvall
Journal:  Protein J       Date:  2004-05       Impact factor: 2.371

2.  Proteomic analysis reveals molecular biological details in varioliform gastritis without Helicobacter pylori infection.

Authors:  Lin Zhang; Yan-Hong Hou; Kai Wu; Jun-Shan Zhai; Nan Lin
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

3.  p53 targets identified by protein expression profiling.

Authors:  Rubaiyat Rahman-Roblick; Uwe Johannes Roblick; Ulf Hellman; Paolo Conrotto; Tao Liu; Susanne Becker; Daniel Hirschberg; Hans Jörnvall; Gert Auer; Klas G Wiman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

4.  Protein profiling of genomic instability in endometrial cancer.

Authors:  Timo Gemoll; Jens K Habermann; Johanna Lahmann; Silke Szymczak; Caroline Lundgren; Nana K Bündgen; Thomas Jungbluth; Britta Nordström; Susanne Becker; Marta I Lomnytska; Hans-Peter Bruch; Andreas Ziegler; Ulf Hellman; Gert Auer; Uwe J Roblick; Hans Jörnvall
Journal:  Cell Mol Life Sci       Date:  2011-07-08       Impact factor: 9.261

5.  Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors.

Authors:  Jens K Habermann; Uwe J Roblick; Brian T Luke; Darue A Prieto; William J J Finlay; Vladimir N Podust; John M Roman; Elisabeth Oevermann; Thomas Schiedeck; Nils Homann; Michael Duchrow; Thomas P Conrads; Timothy D Veenstra; Stanley K Burt; Hans-Peter Bruch; Gert Auer; Thomas Ried
Journal:  Gastroenterology       Date:  2006-10       Impact factor: 22.682

6.  HDAC2 and TXNL1 distinguish aneuploid from diploid colorectal cancers.

Authors:  Timo Gemoll; Uwe J Roblick; Silke Szymczak; Till Braunschweig; Susanne Becker; Bernd-Wolfgang Igl; Hans-Peter Bruch; Andreas Ziegler; Ulf Hellman; Michael J Difilippantonio; Thomas Ried; Hans Jörnvall; Gert Auer; Jens K Habermann
Journal:  Cell Mol Life Sci       Date:  2011-02-03       Impact factor: 9.261

7.  Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.

Authors:  Shawn A Ritchie; Pearson W K Ahiahonu; Dushmanthi Jayasinghe; Doug Heath; Jun Liu; Yingshen Lu; Wei Jin; Amir Kavianpour; Yasuyo Yamazaki; Amin M Khan; Mohammad Hossain; Khine Khine Su-Myat; Paul L Wood; Kevin Krenitsky; Ichiro Takemasa; Masakazu Miyake; Mitsugu Sekimoto; Morito Monden; Hisahiro Matsubara; Fumio Nomura; Dayan B Goodenowe
Journal:  BMC Med       Date:  2010-02-15       Impact factor: 8.775

8.  Multivariate meta-analysis of proteomics data from human prostate and colon tumours.

Authors:  Lina Hultin Rosenberg; Bo Franzén; Gert Auer; Janne Lehtiö; Jenny Forshed
Journal:  BMC Bioinformatics       Date:  2010-09-17       Impact factor: 3.169

9.  Undifferentiated pelvic adenocarcinomas: diagnostic potential of protein profiling and multivariate analysis.

Authors:  U J Roblick; F G Bader; C Lenander; U Hellman; K Zimmermann; S Becker; A Ost; A Alaiya; H-P Bruch; R Keller; L Mirow; B Franzén; T Ried; G Auer; J K Habermann
Journal:  Int J Colorectal Dis       Date:  2008-02-22       Impact factor: 2.571

Review 10.  From the genome to the proteome--biomarkers in colorectal cancer.

Authors:  Jens K Habermann; Franz G Bader; Christian Franke; Kaja Zimmermann; Timo Gemoll; Britta Fritzsche; Thomas Ried; Gert Auer; Hans-Peter Bruch; Uwe J Roblick
Journal:  Langenbecks Arch Surg       Date:  2007-10-16       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.